.png)
Materials
Presentations
Welcome and housekeeping
Edyth Dwyer, Forum
Veronica Miller, Forum
Introductory remarks
Veronica Miller, Forum
Kris Kowdley, Northwest Liver Institute
Pam Vig, Mirum Pharmaceuticals
Session I: Clinical Definition of Acute Cholangitis
Clinical Definition of Acute Cholangitis
Michael Trauner, Medical University of Vienna
Comments from FDA DHN
Ruby Mehta, FDA
Tram Tran*, FDA
Moderated Discussion
Douglas Mogul, Mirum
David Assis, Yale University
Doug Thorburn, Royal Free Hospital
Mark Chatterley, PSC Support
All Participants
Session II: Updates on Patient Experience and Acute Cholangitis
Characterizing Acute Cholangitis Experiences: Updates/Further Analyses from the PSC Flare or Cholangitis Attack Patient Survey
Brian Thorsen, PSC Partners Seeking a Cure
Open Discussion
All Participants
Session III: Biomarker Updates
Fibroblast Activation Related to Outcome in PSC – a Target to Treat
Morten Karsdal, Nordic BioscienceMirum Data Updates- Fibrosis and Bile Acids
Douglas Mogul, Mirum
Open Discussion
All ParticipantsIntroduction to PSC in South Africa
Wendy Spearman, University of Cape Town
Mark Sonderup, University of Cape Town
Session IV: Database Updates
WIND-PSC
Stephen Rossi, PSC Partners Seeking a Cure
IPSCSG Key Initiatives
David Assis, Yale University
Open Discussion
All Participants
* Indicates remote participation
